Epigenetic analyses of the insulin-like growth factor binding protein 1 gene in type 1 diabetes and diabetic nephropathy

Clinical Epigenetics

Volumn 6, Issue 1, 2014, Pages

  Gu, Tianwei ^a   Falhammar, Henrik ^a,b   Gu, Harvest F ^a,b   Brismar, Kerstin ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Diabetic nephropathy; DNA methylation; IGFBP1; Type 1 diabetes

Indexed keywords

BISULFITE; GENOMIC DNA; GLUCOSE; SOMATOMEDIN BINDING PROTEIN 1;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DNA METHYLATION; EPIGENETICS; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GLUCOSE TOLERANCE; HUMAN; IGFBP1 GENE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PYROSEQUENCING; SWEDISH CITIZEN;

EID: 84977624000     PISSN: 18687075     EISSN: 18687083     Source Type: Journal    
DOI: 10.1186/1868-7083-6-10     Document Type: Article

References (29)

1. Pugliese A: The multiple origins of type 1 diabetes. Diabet Med 2013, 30: 135-146.
2. Marshall SM: Diabetic nephropathy in type 1 diabetes: has the outlook improved since the 1980s? Diabetologia 2012, 55: 2301-2306.
3. Stankov K, Benc D, Draskovic D: Genetic and epigenetic factors in etiology of diabetes mellitus type 1. Pediatrics 2013, 132: 1112-1122.
4. Villeneuve LM, Natarajan R: The role of epigenetics in the pathology of diabetic complications. Am J Physiol Renal Physiol 2010, 299: F14-F25.
5. Drong AW, Lindgren CM, McCarthy MI: The genetic and epigenetic basis of type 2 diabetes and obesity. Clin Pharmacol Ther 2012, 92: 707-715.
6. Zhao J, Goldberg J, Bremner JD, Vaccarino V: Global DNA methylation is associated with insulin resistance: a monozygotic twin study. Diabetes 2012, 61: 542-546.
7. Ling C, Del Guerra S, Lupi R, Rönn T, Granhall C, Luthman H, Masiello P, Marchetti P, Groop L, Del Prato S: Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia 2008, 51: 615-622.
8. Xu X, Su S, Barnes VA, De Miguel C, Pollock J, Ownby D, Shi H, Zhu H, Snieder H, Wang X: A genome-wide methylation study on obesity: differential variability and differential methylation. Epigenetics 2013, 8: 522-533.
9. Dick KJ, Nelson CP, Tsaprouni L, Sandling JK, Aïssi D, Wahl S, Meduri E, Morange PE, Gagnon F, Grallert H, Waldenberger M, Peters A, Erdmann J, Hengstenberg C, Cambien F, Goodall AH, Ouwehand WH, Schunkert H, Thompson JR, Spector TD, Gieger C, Trégouët DA, Deloukas P, Samani NJ: DNA methylation and body-mass index: a genome-wide analysis. Lancet 2014, doi: 10.1016/S0140-6736(13)62674-4. [Epub ahead of print].
10. Brismar K, Hall K: Clinical applications of IGFBP-1 and its regulation. Growth Regul 1993, 3: 98-100.
11. Lee PD, Giudice LC, Conover CA, Powell DR: Insulin-like growth factor binding protein-1: recent findings and new directions. Proc Soc Exp Biol Med 1997, 216: 319-357.
12. Petersson U, Ostgren CJ, Brudin L, Brismar K, Nilsson PM: Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): the Söderåkra Cardiovascular Risk Factor Study. Diabetes Metab 2009, 35: 198-205.
13. Lewitt MS, Hilding A, Ostenson CG, Efendic S, Brismar K, Hall K: Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men. Diabetologia 2008, 51: 1135-1145.
14. Gokulakrishnan K, Velmurugan K, Ganesan S, Mohan V: Circulating levels of insulin-like growth factor binding protein-1 in relation to insulin resistance, type 2 diabetes mellitus, and metabolic syndrome (Chennai Urban Rural Epidemiology Study 118). Metabolism 2012, 61: 43-46.
15. Hilding A, Brismar K, Degerblad M, Thorén M, Hall K: Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects. J Clin Endocrinol Metab 1995, 80: 2646-2652.
16. Katz LE, Jawad AF, Ganesh J, Abraham M, Murphy K, Lipman TH: Fasting c-peptide and insulin-like growth factor-binding protein-1 levels help to distinguish childhood type 1 and type 2 diabetes at diagnosis. Pediatr Diabetes 2007, 8: 53-59.
17. Barkai L, Tombacz A: Alterations in insulin-like growth factor binding protein-1 and sex hormone binding globulin levels in type 1 diabetic adolescents with microalbuminuria. Diabetes Care 2001, 24: 605-606.
18. Hong Y, Brismar K, Hall K, Pedersen NL, de Faire U: Associations between insulin-like growth factor-I (IGF-I), IGF-binding protein-1, insulin and other metabolic measures after controlling for genetic influences: results from middle-aged and elderly monozygotic twins. J Endocrinol 1997, 153: 251-257.
19. Gu T, Gu HF, Hilding A, Sjöholm LK, Ostenson CG, Ekström TJ, Brismar K: Increased DNA methylation levels of the insulin-like growth factor binding protein 1 gene are associated with type 2 diabetes in Swedish men. Clin Epigenet 2013, 5: 21. Doi: 10.1186/1868-7083-5-21.
20. Brismar K, Fernqvist-Forbes E, Wahren J, Hall K: Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metab 1994, 79: 872-878.
21. Kaminsky Z, Wang SC, Petronis A: Complex disease, gender and epigenetics. Ann Med 2006, 38: 530-544.
22. Bjornsson HT, Sigurdsson MI, Fallin MD, Irizarry RA, Aspelund T, Cui H, Yu W, Rongione MA, Ekström TJ, Harris TB, Launer LJ, Eiriksdottir G, Leppert MF, Sapienza C, Gudnason V, Feinberg AP: Intra-individual change over time in DNA methylation with familial clustering. JAMA 2008, 299: 2877-2883.
23. Benbassat CA, Maki KC, Unterman TG: Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures. J Clin Endocrinol Metab 1997, 82: 1484-1491.
24. Flyvbjerg A, Bornfeldt KE, Marshall SM, Arnqvist HJ, Orskov H: Kidney IGF-I mRNA in initial renal hypertrophy in experimental diabetes in rats. Diabetologia 1990, 33: 334-338.
25. Hilding A, Möller C, Hall KE: Glucagon and GLP-1 stimulate IGFBP-1 secretion in Hep G2 cells without effect on IGFBP-1 mRNA. Growth Horm IGF Res 2002, 12: 60-68.
26. Samstein B, Hoimes ML, Fan J, Frost RA, Gelato MC, Lang CH: IL-6 stimulation of insulin-like growth factor binding protein (IGFBP)-1 production. Biochem Biophys Res Commun 1996, 228: 611-615.
27. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications; Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15: 539-553.
28. Bang P, Eriksson U, Sara V, Wivall IL, Hall K: Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. Acta Endocrinol (Copenh) 1991, 124: 620-629.
29. Colella S, Shen L, Baggerly KA, Issa JP, Krahe R: Sensitive and quantitative universal pyrosequencing methylation analysis of CpG sites. Biotechniques 2003, 35: 146-150.